Citius Pharmaceuticals News, Citius Pharmaceuticals Quote, CTXR Quote

Citius Pharmaceuticals (NQ:CTXR) Delayed: 0.55 --0 (-0%)

Prev. Close

$0.55

Today 6M 1Y 5Y

Open

$0.55

52 Wk High

$2.50

52 Wk Low

$0.40

Day High

$0.55

Day Low

$0.55

P/E

N/A

EPS

$0.00

Volume

354

Friends, Peers and Foes (?): CTOR, CAH MCK (more...)

ALERTS | RSS

Jun 8, 2026 06:03 AM Form EFFECT CITIUS ONCOLOGY, INC.
Jun 4, 2026 04:30 PM Form SCHEDULE 13D/A CITIUS ONCOLOGY, INC. Filed by: Citius Pharmaceuticals, Inc.
Jun 3, 2026 06:05 AM Form EFFECT Citius Pharmaceuticals,
Jun 1, 2026 04:46 PM Form 424B3 CITIUS ONCOLOGY, INC.
Jun 1, 2026 04:32 PM Form 8-K CITIUS ONCOLOGY, INC. For: Jun 01
Jun 1, 2026 04:32 PM Form 8-K Citius Pharmaceuticals, For: Jun 01
Jun 1, 2026 07:01 AM Citius Oncology highlights phase 1 gynecologic cancer study data
Jun 1, 2026 07:00 AM Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
May 29, 2026 05:01 PM Form DEF 14C CITIUS ONCOLOGY, INC. For: May 29
May 29, 2026 04:33 PM Form S-3 CITIUS ONCOLOGY, INC.

Entities mentioned with CTXR

View All Entities